Selux PBC Separator receives FDA 510(k) clearance
The only FDA cleared, single-platform technology capable of delivering rapid AST results.
Stay updated with breaking news from Breakthrough Devices Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The only FDA cleared, single-platform technology capable of delivering rapid AST results.
A collaborative group of Cedars-Sinai investigators suggest artificial intelligence can accurately assess volume, density of heart fat-both of which are linked to cardiovascular risk
/PRNewswire/ -- SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative technologies and science-based treatments...
SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative technologies and science-based treatments to address the global myopia epidemic, today announced that the U.S. Food and Drug Administration (FDA) has...
This designation assures enhanced FDA cooperation and priority regulatory review of the company's novel medical solution for back pain due to degenerative disc diseaseOXFORD, England--(BUSINESS WIRE)--ORTHOSON, a medtech innovator developing a portfolio of novel treatments for back pain, today announced that its Bio...